Global X - Genomics & Biotechnology ETF (GNOM) Dividend Yield, History & Forecast

Global X - Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund (ETF) listed on the NASDAQ Global Market. It pays a current dividend yield of 1.16% ($0.65 per share annually (TTM)). The most recent ex-dividend date was June 29, 2026, with payment scheduled for July 7, 2026. market capitalization is approximately $79M.

GNOM fund composition

GNOM holds 50 positions, with 46.1% of assets in its ten largest. It charges an expense ratio of 0.50%, and manages $80.2M.

Top 10 holdings

HoldingWeight
GHGUARDANT HEALTH INC6.38%
ILMNILLUMINA INC5.54%
TWSTTWIST BIOSCIENCE CORP4.96%
TXG10X GENOMICS INC-CLASS A4.92%
NTRANATERA INC4.54%
TECHBIO-TECHNE CORP4.34%
ARWRARROWHEAD PHARMACEUTICALS IN4.04%
BMRNBIOMARIN PHARMACEUTICAL INC3.91%
VRTXVERTEX PHARMACEUTICALS INC3.84%
QGENQIAGEN N.V.3.65%

Sector allocation

Healthcare99.8%Technology0.3%

Frequently Asked Questions about Global X - Genomics & Biotechnology ETF (GNOM)

What is Global X - Genomics & Biotechnology ETF's dividend yield?
Global X - Genomics & Biotechnology ETF (GNOM) pays a current trailing twelve-month dividend yield of 1.16%, which works out to $0.65 per share annually based on the most recent payout schedule.
When does Global X - Genomics & Biotechnology ETF pay distributions?
The most recent ex-dividend date was June 29, 2026. The next scheduled dividend payment date is July 7, 2026.
What does Global X - Genomics & Biotechnology ETF invest in?
The Global X Genomics & Biotechnology ETF, known by its ticker GNOM, aims to closely track the performance of the Solactive Genomics Index, reflecting both its price appreciation and any generated income. This mirroring occurs before the deduction of the ETF's internal fees and expenses.